Cross Border Impact Ventures
Toronto, Ontariocrossborder.ventures
Overview
Cross-Border Impact Ventures is an impact venture capital firm on a mission to revolutionize venture investing in health technology. They invest in world class, early-growth stage health technology companies commercializing medical devices, diagnostics, therapeutics, and digital health innovations that benefit women, children and adolescents. The firm targets venture returns for its investors and empower its portfolio companies to reach beyond their primary markets in the United States and Europe to reach more vulnerable populations in emerging markets.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| BACTOLIFE | Jan 2026 | Series B | Lead |
| Pendulum | Feb 2025 | Seed | Co-investor |
| Oxford Cancer Analytics | Jan 2025 | Series A | Lead |
| OncoLens | Oct 2024 | Series B | Lead |
| Axena Health | Jun 2024 | Series A Extension | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.